DSM

DSM Reorganizes to Cut Costs and Strengthen Focus

ChemicalInvest Launched by DSM and CVC

DSM Dyneema Names Motahari Pour to Succeed De Reuver as President

Ardian Acquires ES and IM from DPx Holdings

Polet to Succeed Westerbeek at DSMEP

Patrik Wohlhauser Terminated as Evonik COO

Atul Thakrar New Head of DSM’s Bio-based Products & Services

DSM Upgrades for Sustainability at Emmen

DSM and Ascend in global PA 6.6 Compounds Alliance

DSM Now Said to Be in Evonik’s Crosshairs

DSM Dyneema Finalizes Cubic Tech Deal

Sale of DSM Synres Completed

Brightlands Materials R&D Center Has Been Launched

Topics • Strategy

Chemical Players Expect Gains on Cheap Oil and Euro

DSM Upgrades US Waterborne Coatings Facility

DSM Finalizes Sale of Euroresins to Cathay Investments

DSM May Sell or Spin Off Underperforming Assets

DSM’s New PA 6 Plant to be Built in US state of Georgia

A Restructured Evonik May Seek a Major Acquisition

Archroma: Valerie Diele-Braun appointed President Paper Solutions

Topics • Strategy

Attractive Areas in China’s Chemical Industry

Topics • Strategy

Focus on Sustainability Makes Perfect Business Sense

DSM to Build New PA 6 Plant in North America

Global Chemical Industry Presents Mixed Results for 2013

New Pharma Services JV of DSM and JLL Launched

DSM Resumes Share Buyback Plan

Changes at the Top of the European Fine Chemicals Group

Marcel Lubben Named President of Reverdia

DSM to Fold Pharma Arm into Venture with Private Equity Firm

Topics • Chemistry

Sustainable Succinic Acid

Chinese Acquisitions Gives Local Access to Foreign Chemical Companies

Topics • Technology

United in Philosophy and Approach

DSM: Acquisitions Help Boost Q2 Profits

DSM to Acquire Interest in Andre Pectin (China)

DSM Opens cGMP Biopharmaceutical Manufacturing Operation in Brisbane, Australia

62 more articles

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Global Impact Coalition (GIC)

Siemens Joins the Global Impact Coalition

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

Expert Insights

ADCs for Precision Cancer Therapy

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Royal DSM N.V.

Microinnova Engineering GmbH

DSM Pharmaceutical Products

Chemgineering Technology GmbH

LANXESS Deutschland GmbH

Together for Sustanability (TFS)

Jan Ramakers Fine Chemical

Frost & Sullivan

Advancy GmbH

DuPont Company

Managm. Consult. Chemicals

PP Consulting

World Economic Forum